Pages Menu
Categories Menu

News

REPRIEVE and Washington University Featured in the St. Louis Post-Dispatch

Posted by on May 27, 2015 in News | Comments Off on REPRIEVE and Washington University Featured in the St. Louis Post-Dispatch

Washington University’s participation in the REPRIEVE trial is featured in the St. Louis Post-Dispatch!

read more

Healio Article Outlining the Basis and Goals for REPRIEVE

Posted by on May 26, 2015 in News | Comments Off on Healio Article Outlining the Basis and Goals for REPRIEVE

Amazing article outlining the basis and goals for REPRIEVE! Click here to find out more!

read more

REPRIEVE in the Recent HANC Newsletter

Posted by on May 8, 2015 in News | Comments Off on REPRIEVE in the Recent HANC Newsletter

May 2015 HANC Newsletter

read more

Exciting News from MGH About the REPRIEVE Trial

Posted by on Apr 24, 2015 in News | Comments Off on Exciting News from MGH About the REPRIEVE Trial

Exciting news from Massachusetts General Hospital about the REPRIEVE trial! Click here to learn more!

read more

REPRIEVE is on ClinicalTrials.gov

Posted by on Apr 17, 2015 in News, Uncategorized | Comments Off on REPRIEVE is on ClinicalTrials.gov

REPRIEVE is recruiting on clinicaltrials.gov

read more

NIH Announces REPRIEVE Trial Launch

Posted by on Apr 16, 2015 in News, Uncategorized | Comments Off on NIH Announces REPRIEVE Trial Launch

NHLBI and NIAID announce launch of the REPRIEVE Trial: http://www.nih.gov/news/health/apr2015/nhlbi-15.htm

read more

First participant randomized in REPRIEVE

Posted by on Mar 27, 2015 in News | Comments Off on First participant randomized in REPRIEVE

The first participant has been randomized in the REPRIEVE trial! We are so excited to have reached this major milestone and are continuing to move forward to randomize many more participants into this ground breaking trial to test whether a daily dose of a statin will reduce the risk of cardiovascular disease among HIV-infected individuals.

read more

Recent Mention of REPRIEVE by the ACTG

Posted by on Mar 23, 2015 in News | Comments Off on Recent Mention of REPRIEVE by the ACTG

Recent mention of REPRIEVE by the ACTG!  Please click here to read more!

read more

The REPRIEVE Trial is Open to Enrollment!

Posted by on Mar 17, 2015 in News, Uncategorized | Comments Off on The REPRIEVE Trial is Open to Enrollment!

As of Tuesday, March 17th, 2015 the REPRIEVE Trial is now open to enrollment!  Congratulations to Washington University for being the first site ready to enroll!!! An announcement from the ACTG Network Coordinating Center regarding this exciting milestone was sent out to sites participating in REPRIEVE earlier today.

read more

Dr. Monica Shah Publishes on High Priority Research Including REPRIEVE Trial

Posted by on Mar 13, 2015 in News | Comments Off on Dr. Monica Shah Publishes on High Priority Research Including REPRIEVE Trial

Please see attached link to article “Stimulating High Impact HIV-Related Cardiovascular Research: Recommendations From a Multidisciplinary NHLBI Working Group on HIV-Related Heart, Lung, and Blood Disease” by Dr. Monica Shah published in the February 24, 2015 issue of the Journal of the American College of Cardiology. http://www.ncbi.nlm.nih.gov/pubmed/25677433

read more